Showing results (1-10 of 238) with videos related to
Sort By:
Pageof 24
Journal of Biopharmaceutical Statistics|February 19, 2024
A basket trial design based on constrained hierarchical Bayesian model for latent subgroupsKentaro Takeda, Atsuki Hashimoto, Shufang Liu, et al.Pharmaceutical Statistics|September 27, 2022
An adaptive biomarker basket design in phase II oncology trialsShufang Liu, Kentaro Takeda, Alan RongStatistics in Medicine|October 26, 2021
Constrained hierarchical Bayesian model for latent subgroups in basket trials with two classifiersKentaro Takeda, Shufang Liu, Alan RongPharmaceutical Statistics|December 4, 2021
TITE-gBOIN: Time-to-event Bayesian optimal interval design to accelerate dose-finding accounting for toxicity gradesKentaro Takeda, Qing Xia, Shufang Liu, et al.Journal of Biopharmaceutical Statistics|September 17, 2025
BOP2-FE: Bayesian optimal phase II design with futility and efficacy-stopping boundariesXinling Xu, Atsuki Hashimoto, Belay B Yimer, et al.Therapeutic Innovation & Regulatory Science|April 22, 2023
Comparison Between Simultaneous and Sequential Utilization of Safety and Efficacy for Optimal Dose Determination in Bayesian Model-Assisted DesignsRan Li, Kentaro Takeda, Alan RongPharmaceutical Statistics|November 17, 2025
Statistical Consideration for Event-Free Survival With Cure Rate in Acute Myeloid Leukemia StudiesYuichiro Kaneko, Kentaro Takeda, Shufang Liu, et al.Pharmaceutical Statistics|January 14, 2020
Study design of single-arm phase II immunotherapy trials with long-term survivors and random delayed treatment effectChenghao Chu, Shufang Liu, Alan RongPharmaceutical Statistics|July 31, 2018
Weighted log-rank test for time-to-event data in immunotherapy trials with random delayed treatment effect and cure rateShufang Liu, Chenghao Chu, Alan RongGan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2022
[Introduction of Oncology Dose-Finding Trial Designs]Kentaro TakedaPageof 24